316 related articles for article (PubMed ID: 25349649)
1. High-density lipoprotein and atherosclerosis: Roles of lipid transporters.
Uehara Y; Saku K
World J Cardiol; 2014 Oct; 6(10):1049-59. PubMed ID: 25349649
[TBL] [Abstract][Full Text] [Related]
2. High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases.
Ikenaga M; Higaki Y; Saku K; Uehara Y
J Atheroscler Thromb; 2016; 23(4):385-94. PubMed ID: 26830201
[TBL] [Abstract][Full Text] [Related]
3. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
[TBL] [Abstract][Full Text] [Related]
4. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
[TBL] [Abstract][Full Text] [Related]
5. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
Wang N; Lan D; Chen W; Matsuura F; Tall AR
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
[TBL] [Abstract][Full Text] [Related]
6. Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI.
Lorenzi I; von Eckardstein A; Radosavljevic S; Rohrer L
Biochim Biophys Acta; 2008; 1781(6-7):306-13. PubMed ID: 18485926
[TBL] [Abstract][Full Text] [Related]
7. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.
Berrougui H; Khalil A
Rejuvenation Res; 2009 Apr; 12(2):117-26. PubMed ID: 19405812
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-I improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1.
Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA
FASEB J; 2019 Jul; 33(7):8479-8489. PubMed ID: 30970222
[TBL] [Abstract][Full Text] [Related]
9. High-Density Lipoprotein-Targeted Therapy and Apolipoprotein A-I Mimetic Peptides.
Uehara Y; Chiesa G; Saku K
Circ J; 2015; 79(12):2523-8. PubMed ID: 26548857
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin's mechanisms in high-density lipoprotein biogenesis and cholesterol efflux.
Hafiane A; Daskalopoulou SS
Metabolism; 2020 Dec; 113():154393. PubMed ID: 33058851
[TBL] [Abstract][Full Text] [Related]
11. [Role of the ABC transporters A1 and G1, key reverse cholesterol transport proteins, in atherosclerosis].
Demina EP; Miroshnikova VV; Schwarzman AL
Mol Biol (Mosk); 2016; 50(2):223-30. PubMed ID: 27239842
[TBL] [Abstract][Full Text] [Related]
12. FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice.
Uehara Y; Ando S; Yahiro E; Oniki K; Ayaori M; Abe S; Kawachi E; Zhang B; Shioi S; Tanigawa H; Imaizumi S; Miura S; Saku K
J Am Heart Assoc; 2013 May; 2(3):e000048. PubMed ID: 23709562
[TBL] [Abstract][Full Text] [Related]
13. Targeting high-density lipoproteins: update on a promising therapy.
Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
[TBL] [Abstract][Full Text] [Related]
14. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
15. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment.
Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ
Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519
[TBL] [Abstract][Full Text] [Related]
16. D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.
Xie Q; Zhao SP; Li F
Tohoku J Exp Med; 2010 Mar; 220(3):223-8. PubMed ID: 20208418
[TBL] [Abstract][Full Text] [Related]
17. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.
Brewer HB; Remaley AT; Neufeld EB; Basso F; Joyce C
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1755-60. PubMed ID: 15319263
[TBL] [Abstract][Full Text] [Related]
18. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
Zannis VI; Chroni A; Krieger M
J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
